There were significant differences in hypertension and the use of clopidogrel, β-blockers, statins, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), and nitrates among the ACS, CSA, and CPS groups. This evidence concerns the gene ACE and hypertensive disorder.